戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 l hemolytic uremic syndrome and catastrophic antiphospholipid antibody syndrome.
2 e appropriate laboratory results make up the antiphospholipid antibody syndrome.
3 id-binding protein and an autoantigen in the antiphospholipid antibody syndrome.
4 ociated with thrombosis in patients with the antiphospholipid antibody syndrome.
5 ave also updated information about pediatric antiphospholipid antibody syndrome.
6  and relapse of autoimmune diseases, such as antiphospholipid antibody syndrome.
7 pholipid antibodies, including patients with antiphospholipid antibody syndrome.
8 nism of thrombosis and pregnancy loss in the antiphospholipid-antibody syndrome.
9 rment within SLE and related conditions (eg, antiphospholipid antibody syndrome, active vs inactive S
10 d IgG fractions from three patients with the antiphospholipid-antibody syndrome and from normal contr
11 and autoimmune conditions, such as lupus and antiphospholipid antibody syndrome, and, more recently,
12                                              Antiphospholipid antibody syndrome (APAS) is characteriz
13 End-stage renal disease (ESRD) patients with antiphospholipid antibody syndrome (APAS) remain at high
14                                        Using antiphospholipid antibody syndrome (APS) as a model for
15                                              Antiphospholipid antibody syndrome (APS) is a complex au
16 optimal clinical management of patients with antiphospholipid antibody syndrome (APS) is uncertain be
17                            Patients with the antiphospholipid antibody syndrome (APS) often experienc
18 potential role of new oral anticoagulants in antiphospholipid antibody syndrome (APS) remains uncerta
19 cardiolipin (CL), are found in patients with antiphospholipid antibody syndrome (APS).
20 es that were all isolated from patients with antiphospholipid antibody syndrome (APS); testing was al
21                       New antibody tests for antiphospholipid antibody syndrome are available with in
22 ascular thrombosis and pregnancy loss in the antiphospholipid-antibody syndrome are unknown.
23 iolipin (anti-CL) antibodies, diagnostic for antiphospholipid antibody syndrome, are associated with
24 wledge of the clinical syndrome that we call antiphospholipid antibody syndrome has also progressed.
25  understanding of the pathophysiology behind antiphospholipid antibody syndrome has led to novel appr
26 idelines for the treatment and management of antiphospholipid antibody syndrome have been established
27                   The diagnostic criteria of antiphospholipid antibody syndrome have been reviewed an
28                                          The antiphospholipid antibody syndrome is an important cause
29 plant-associated thrombotic microangiopathy, antiphospholipid antibody syndrome, myasthenia gravis, a
30 er pertaining to anticoagulant choice, as in antiphospholipid antibody syndrome, or to addressing a n
31 d cause valvular vegetations associated with antiphospholipid antibody syndrome, which would be a new
32                                              Antiphospholipid antibody syndrome with valvular vegetat